Hepatitis D awareness campaign highlights testing gaps for hepatitis B patients
Executive summary: On July 28, 2026, PR Newswire distributed a World Hepatitis Day statement warning that hepatitis D continues to be an under‑recognized risk for individuals with hepatitis B. Hepatitis D accelerates liver disease progression and increases mortality, yet testing and treatment pathways are often absent from standard HBV care.
Who is involved: The warning was issued by global hepatitis advocacy groups referencing WHO guidance and was disseminated via PR Newswire from Beijing.
Likely next: Stakeholders may advocate for updated screening guidelines and increased funding for HDV‑specific diagnostics and therapeutics later in 2026.
On World Hepatitis Day 2026, a PR Newswire release noted that hepatitis D remains an overlooked threat for people living with hepatitis B, emphasizing that HDV only occurs in HBV co‑infection and is the most severe form of chronic viral hepatitis. The statement urged removal of barriers to testing, treatment and care but did not introduce new data or policy measures. The message reflects ongoing advocacy to integrate HDV screening into existing hepatitis B programs.
Timeline
- — Hepatitis D Remains an Overlooked Threat for People Living with Hepatitis B (PR Newswire)
Sources
Related cases
- Fosun Pharma launches up to HK$1 billion H‑share buyback to bolster shareholder returns
- K-Royal Culture Festival Fall 2026 ticket sales open Sept 4, poised to boost cultural tourism revenue
- Retired teacher Janice Burnette launches third faith-based early-reader book, signaling sustained niche demand for scripture-based literacy materials
- AusperBio secures $120 million Series C to push AHB‑137 toward Phase 3 and expand its HBV pipeline
- A new practical guide promotes bus travel for international visitors to Kanazawa, seeking to boost tourism and local transit use
- Patient preference for surgeon‑led dental implant care signals a shift away from corporate dentistry models